Executive Summary
The patent dispute between BASF subsidiaries trinamiX GmbH and trinamiX Sensing LLC and Apple illustrates how an innovation can travel far beyond the market in which it originated. According to the complaint, the technology began with an unexpected effect observed during BASF’s organic solar-cell research and later developed into capabilities involving three-dimensional sensing, material identification, and biometric authentication. The court will determine whether Apple infringed the asserted patents, but the history behind the case already presents an important management lesson: A patent portfolio should be evaluated not only by what its inventions were originally created to do, but also by the capabilities those inventions make possible in entirely different markets.
Listen to the Executive Briefing (11 minutes)
How an Innovation Crossed Into a Non-Adjacent Market
Around 2010, BASF researchers working on organic solar cells encountered a material effect that initially appeared to be a flaw in the technology they were developing. The conventional response would have been to correct the flaw and continue pursuing the original research objective. Instead, the researchers recognized that the effect might support other capabilities, including sensing and three-dimensional measurement. That shift in perspective changed the commercial trajectory of the discovery. Rather than defining the innovation solely by its relationship to solar energy, BASF began exploring what the underlying physical effect could enable. Early three-dimensional camera prototypes followed, along with patent applications intended to protect the developing technology. The critical insight was not that the original solar-cell research had produced an unexpected result; it was that the unexpected result might solve problems unrelated to solar energy.
The transition from solar-cell research to biometric authentication did not occur in a single leap. BASF created trinamiX as a dedicated company to develop and commercialize the sensing technology, giving the innovation an organizational home outside the research program that produced it. The underlying capability was progressively translated into applications involving distance measurement, material identification, and the analysis of reflected light. Those applications, in turn, created possible commercial pathways in consumer electronics, automobiles, industrial systems, and access control. In facial authentication, the relevant problem is not merely recognizing the shape of a face. A secure system may also need to determine whether it is observing human skin rather than a photograph, mask, silicone replica, or another material intended to deceive it. A technology that began in energy research had therefore become potentially relevant to one of the central challenges in biometric security: distinguishing a living person from a convincing imitation.
This history exposes a weakness in the way many organizations evaluate intellectual property. Scientists naturally view an invention through the research problem they were trying to solve, patent professionals concentrate on protecting what has been claimed, and business-unit leaders focus on the customers and markets they already understand. Each perspective is necessary, but none is sufficient to reveal an opportunity in a non-adjacent market with different terminology, competitors, purchasing decisions, and routes to adoption. A patent search can identify protected claims and related technologies, but it cannot determine by itself which other industries face a comparable problem, whether customers will pay to solve it, or how the invention might reach them. The more productive starting point is to translate the invention into a clear statement of capability and then ask: Where else does this capability solve a consequential problem, and who in that market would value it most?
The BASF–Apple case represents the enforcement stage of this particular story, not the beginning of it. trinamiX alleges that later generations of Apple devices incorporate material- and skin-detection capabilities covered by seven of its patents, although Apple’s response and the ultimate legal outcome remain to be determined. The public complaint does not establish whether the companies engaged in licensing discussions before suit, and no such negotiations should be assumed. What the available history does show is that BASF recognized a potentially valuable discovery, protected it, created a specialized organization to develop it, and pursued applications far removed from the research program in which it originated. That progression captures the opportunity Horizon is designed to examine. Markets define where an innovation begins, but capabilities determine where it can ultimately create value. The next important growth opportunity inside a patent portfolio may therefore be found not by looking more closely at the company’s existing market, but by looking beyond it.